# A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

> **NCT00258076** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 53 (actual)

## Conditions studied

- Contraception
- Female Contraception

## Interventions

- **DRUG:** EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE

## Key facts

- **NCT ID:** NCT00258076
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258076, "A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00258076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*